Heidelberg Pharma AG (HPHA) Stock Price & News

All values in EUR	Nov 2025	Feb 2026	May 2026	Aug 2026
Revenue	21.44K	3.03M	4.34M	1.92M
Cost of goods sold	90.34K	374.20K	380.12K	-754.32K
Cost of revenue	90.34K	374.20K	380.12K	-754.32K
Research and development expenses	17.74M	6.07M	2.27M	4.97M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2.61M	1.57M	1.21M	-2.78M
Operating expense	22.12M	7.76M	3.82M	8.36M
Total operating expenses	22.21M	8.13M	4.20M	7.61M
Operating income	-22.19M	-5.10M	144.28K	-5.69M
Other non operating income	-4.90M	1.04M	816.42K	535.86K
EBT including unusual items	-20.18M	-4.28M	1.29M	-5.26M
EBT excluding unusual items	-20.31M	-4.28M	1.29M	-5.26M
Income tax expense	1.05M	-	425.14K	-140.00
Effective tax rate	-5.21%	-	33.01%	-
Other operating expenses	1.77M	110.93K	345.87K	6.17M
Net income	-21.23M	-4.28M	862.76K	-5.26M
Net profit margin	-99,007.38%	-141.02%	19.86%	-274.08%
Earnings per share	-	-	-	-
Interest and investment income	1.61M	87.21K	27.61K	1.12K
Interest expense	-926.00	-711.00	-404.00	-114.82K
Net interest expenses	1.61M	86.50K	27.20K	-113.70K
Depreciation and amortization charges	-	-	-	-
EBITDA	-22.13M	-5.03M	205.24K	-5.62M
Gain or loss from assets sale	4.07K	14.90K	-106.38K	-

Ask anything